Oric Pharmaceuticals, Inc. (ORIC) › Shareholders' EquityOric Pharmaceuticals, Inc. (ORIC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$43.61M2018: -$64.43M2019: -$90.08M2020: $289.78M2021: $272.98M2022: $222.35M2023: $224.09M2024: $243.12M2025: $384.36M$384.36M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$384.36M+58.1%2024$243.12M+8.5%2023$224.09M+0.8%2022$222.35M-18.5%2021$272.98M-5.8%2020$289.78M+421.7%2019-$90.08M-39.8%2018-$64.43M-47.7%2017-$43.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share